India Cell And Gene Therapy Clinical Trial Services Market (2025-2031) | Competitive Landscape, Trends, Growth, Companies, Value, Segmentation, Industry, Analysis, Outlook, Size & Revenue, Forecast, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F

3.3 India Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle

3.4 India Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces

3.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F

3.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F

3.8 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India

4.2.2 Growing investments in research and development of cell and gene therapy technologies

4.2.3 Rising demand for personalized medicine and targeted therapies in the Indian healthcare sector

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for cell and gene therapy clinical trials in India

4.3.2 Limited infrastructure and expertise in conducting advanced clinical trials for cell and gene therapies in the country

6.1 India Cell And Gene Therapy Clinical Trial Services Market, By Service

6.1.1 Overview and Analysis

6.1.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F

6.1.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F

6.1.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F

6.1.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F

6.1.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F

6.1.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F

6.1.8 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Cell And Gene Therapy Clinical Trial Services Market, By Phase

6.2.1 Overview and Analysis

6.2.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F

6.2.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F

6.2.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F

6.2.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F

6.3 India Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas

6.3.1 Overview and Analysis

6.3.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F

6.3.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.3.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F

6.3.7 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.4 India Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type

6.4.1 Overview and Analysis

6.4.2 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.4.3 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F

6.4.4 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.4.5 India Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries

7.2 India Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries

8.1 Patient recruitment and retention rates for cell and gene therapy clinical trials

8.2 Time-to-market for new cell and gene therapy products in India

8.3 Number of partnerships and collaborations between Indian research institutions and global biopharmaceutical companies in the field of cell and gene therapy

9.1 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F

9.2 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F

9.3 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F

9.4 India Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

10.1 India Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024

10.2 India Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters